Previous association studies also suggested that altered regulation of p16INK4a expression may result in human age-associated phenotypes such as type 2 diabetes6, coronary heart disease7, cancer susceptibility8, 9, 10, 11, and longevity12, 13, 14. Here, CDKN2A is linked to cancer.